Adjunctive Argatroban or Eptifibatide Shows No Benefit with Thrombolysis in Thrombectomy Patients: JAMA
A recent study published in the Journal of American Medical Association revealed that adding argatroban or eptifibatide to intravenous thrombolysis did not improve reperfusion rates or clinical outcomes in patients undergoing endovascular thrombectomy. The findings from the Multi-Arm Optimization of Stroke Thrombolysis (MOST) trial was conducted between 2019 and 2023. The study followed patients for 90 […]